Emerald Advisers, LLC Tg Therapeutics, Inc. Transaction History

Emerald Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$15.2 - $35.51 $135,903 - $317,494	-8,941 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$32.5 - $48.96 $7.89 Million - $11.9 Million	-242,916 Reduced 96.45%	8,941 $347,000
Q1 2021 Apr 29, 2021	BUY	$41.61 - $54.3 $10.5 Million - $13.7 Million	251,857 New	251,857 $12.1 Million

347

88M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.86B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Emerald Advisers, LLC with notifications on news.